About SeaStar Medical Holding Corporation
https://www.seastarmedical.comSeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients.
CEO
Eric Schlorff
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2026-01-05 | Reverse | 1:10 |
| 2024-06-10 | Reverse | 1:25 |
ETFs Holding This Stock
Summary
Showing Top 1 of 1
Ratings Snapshot
Rating : C+
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:377.38K
Value:$954.76K
GEODE CAPITAL MANAGEMENT, LLC
Shares:258.92K
Value:$655.07K
MILLENNIUM MANAGEMENT LLC
Shares:179.67K
Value:$454.57K
Summary
Showing Top 3 of 30
About SeaStar Medical Holding Corporation
https://www.seastarmedical.comSeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $183K ▼ | $3.75M ▲ | $-3.47M ▼ | -1.9K% ▼ | $-1.3 ▼ | $-3.46M ▼ |
| Q2-2025 | $338K ▲ | $2.07M ▼ | $-2M ▲ | -592.31% ▲ | $-1.1 ▲ | $-1.99M ▲ |
| Q1-2025 | $293K ▲ | $4.12M ▼ | $-3.77M ▲ | -1.29K% ▲ | $-4.4 ▲ | $-3.76M ▲ |
| Q4-2024 | $67K ▼ | $4.83M ▲ | $-4.42M ▲ | -6.6K% ▼ | $-9 ▲ | $-4.67M ▼ |
| Q3-2024 | $68K | $4.52M | $-4.48M | -6.59K% | $-11 | $-4.21M |
What's going well?
The company has no debt burden this quarter and still earns some interest income. Gross margins remain high, suggesting the core product is profitable if sales can scale.
What's concerning?
Sales nearly halved, expenses soared, and the company lost almost $3.5 million on just $183,000 in revenue. Heavy share dilution also hurts existing shareholders.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $13.76M ▲ | $15.53M ▲ | $4.07M ▼ | $11.46M ▲ |
| Q2-2025 | $6.3M ▲ | $8.38M ▲ | $5.04M ▼ | $3.34M ▲ |
| Q1-2025 | $5.3M ▲ | $7.6M ▲ | $7.03M ▲ | $565K ▲ |
| Q4-2024 | $1.82M ▼ | $4.66M ▲ | $6.84M ▲ | $-2.18M ▼ |
| Q3-2024 | $2.08M | $4.59M | $6.64M | $-2.05M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-3.47M ▼ | $-3.84M ▼ | $0 | $11.3M ▲ | $7.46M ▲ | $-3.84M ▼ |
| Q2-2025 | $-2M ▲ | $-3.01M ▼ | $0 | $4.01M ▼ | $1.01M ▼ | $-3.01M ▼ |
| Q1-2025 | $-3.77M ▲ | $-2.65M ▲ | $0 | $6.13M ▲ | $3.48M ▲ | $-2.65M ▲ |
| Q4-2024 | $-4.42M ▲ | $-4.69M ▲ | $0 | $4.43M ▼ | $-263K ▼ | $-4.69M ▲ |
| Q3-2024 | $-4.48M | $-5M | $0 | $5.91M | $903K | $-5M |
CEO
Eric Schlorff
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2026-01-05 | Reverse | 1:10 |
| 2024-06-10 | Reverse | 1:25 |
ETFs Holding This Stock
Summary
Showing Top 1 of 1
Ratings Snapshot
Rating : C+
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:377.38K
Value:$954.76K
GEODE CAPITAL MANAGEMENT, LLC
Shares:258.92K
Value:$655.07K
MILLENNIUM MANAGEMENT LLC
Shares:179.67K
Value:$454.57K
Summary
Showing Top 3 of 30